Reignite the Spark: How Hormones, Habits, and Peptides Can Help Restore Low Libido

Post-menopausal women have several options their provider may discuss: vaginal estrogen (cream, ring, or tablet, for tissue comfort and lubrication), systemic HRT with testosterone (estrogen, progesterone and physiological female testosterone), PT-141 (desire-support peptide which acts at the brain level), oxytocin therapy (for bonding and closeness), DHEA vaginal suppositories (local hormone support for vaginal tissue), and medical-grade lubricants and moisturizers. At Balanced, post-menopausal sexual health plans often combine several of these — because multiple factors often change at the same time. Individual results vary.

Sexual Health →  ·  Hormone Therapy →

Oxytocin — the ‘bonding hormone’ — plays a significant role in sexual function beyond social connection. In sexual health context, it is studied for its role in arousal, physical sensation and emotional connection during intimacy. Individual results vary.

At Balanced, oxytocin is available as a compounded prescription — sublingual troche or nasal spray, used as your provider directs. The effect is subtle but meaningful: patients describe feeling more present, more physically sensitive, and more emotionally connected.

Oxytocin works through a different mechanism than PT-141 (desire pathways) or testosterone (libido drive). It enhances the experience of intimacy rather than the drive toward it. Your provider may combine testosterone (desire), PT-141 (arousal) and oxytocin (sensation and connection) in one plan.

Your provider reviews possible side effects with you; some patients notice mild warmth or relaxation.

Sexual Health →  ·  Women’s Sexual Health →

Testosterone is the primary hormone driving sexual desire in women — not estrogen, as commonly assumed. While estrogen supports vaginal health and physical comfort during intimacy, testosterone is what creates the wanting. The neurological drive for sexual activity is mediated through androgen receptors in the brain that respond to testosterone.

Women produce testosterone naturally — about 5–10% of male levels — and it peaks in the mid-20s before declining steadily. By menopause, a woman’s testosterone may be 50–70% lower than peak levels. This decline directly correlates with the loss of spontaneous desire that many women experience.

The decline is often gradual enough that women normalize it: “I’m just not as interested as I used to be” becomes an accepted reality rather than a recognized symptom of hormonal change. It is worth raising with your provider.

At Balanced, women’s testosterone is prescribed at physiological female doses (much lower than male TRT) and monitored with labs. Your provider reviews your response at follow-up. Individual results vary. Combined with estrogen (for physical comfort) and progesterone (for mood and sleep), testosterone can be part of a hormone plan for sexual wellness. Individual results vary.

Women’s Sexual Health →  ·  Hormone Therapy →

Oxytocin is the “bonding hormone” — produced naturally during physical intimacy, orgasm, breastfeeding, and close social connection. Supplemental oxytocin therapy is studied for its role in the emotional and sensory side of intimacy.

It is prescribed as a sublingual troche or nasal spray, and your provider sets the oxytocin plan. Individual results vary.

Oxytocin works through different pathways than testosterone (which drives desire) or PDE5 inhibitors (which improve blood flow). It addresses the emotional and sensory dimensions of sexual experience — making it a valuable addition for patients who have adequate desire and function but want to enhance the quality of the experience.

At Balanced, oxytocin is prescribed from licensed compounding pharmacies at individualized doses. It’s often part of a sexual health plan alongside hormone optimization and, when appropriate, PT-141 for desire support.

Sexual Health →  ·  Peptide Therapy →

Most sexual health treatments at Balanced are not covered by standard insurance. Hormone therapy, peptide therapy (PT-141), and oxytocin are typically categorized as wellness or optimization treatments that fall outside conventional insurance coverage. Some exceptions may exist: testosterone testing and treatment for diagnosed hypogonadism may have insurance pathways, though coverage varies significantly. FDA-approved medications like Addyi (for female HSDD) may have coverage under some plans. At Balanced, we operate on a direct-pay model that avoids insurance restrictions on what can be prescribed. HSA/FSA funds may be applicable for medical sexual health evaluations.

Sexual Health →  ·  Memberships →

Yes. Female sexual desire is regulated by a complex hormonal interplay — and when any component shifts, desire changes. Estrogen supports vaginal health, lubrication, and blood flow to sexual organs. Testosterone — often overlooked in women — is the primary hormone driving desire at the brain level. Progesterone affects mood, sleep, and anxiety, all of which influence receptivity to intimacy.

During perimenopause and menopause, all three decline: estrogen drops causing vaginal dryness and discomfort, testosterone falls reducing desire signaling, and progesterone decreases disrupting sleep and increasing anxiety. The combined effect is that intimacy becomes physically uncomfortable, neurologically uninteresting, and emotionally inaccessible — all at once.

Cortisol makes everything worse. Chronic stress directly suppresses estrogen and testosterone production through the HPA axis. A woman under sustained stress is biologically deprioritizing reproduction — her body is in survival mode.

At Balanced, sexual health evaluation includes all relevant hormones: estradiol, progesterone, testosterone (total and free), DHEA-S, cortisol, thyroid, and prolactin. Your provider uses these results to decide what, if anything, to adjust. Individual results vary.

Women’s Sexual Health →  ·  Hormone Therapy →

Treatment depends on the underlying cause — which is why labs come first. At Balanced, the most common interventions include hormone optimization (TRT for men, HRT including testosterone for women), PT-141 peptide therapy (acts on melanocortin receptors in the brain to directly increase desire and arousal), oxytocin therapy (supports bonding, closeness, and arousal), and lifestyle modifications (sleep optimization, stress management, cortisol reduction).

For men with erectile dysfunction alongside low desire, the TRT Membership includes a Cialis prescription, and PT-141 can be added for the desire component that PDE5 inhibitors don’t address. For women, vaginal estrogen can resolve the physical discomfort (dryness, pain) that makes intimacy unpleasant, while testosterone and PT-141 address the desire signal.

The most effective approach treats all contributing factors simultaneously rather than targeting one in isolation. A woman whose low libido stems from estrogen decline plus cortisol elevation plus poor sleep needs interventions across all three — not just a single prescription.

At Balanced, sexual health consultations are clinical, private, and non-judgmental. This is a biological issue, not a personal failing — and it is worth a real conversation with your provider.

Sexual Health →  ·  Peptide Therapy →

PT-141 (Bremelanotide) is a peptide that acts on melanocortin receptors in the brain to increase sexual desire and arousal. Unlike Viagra or Cialis — which work on blood flow mechanics downstream — PT-141 targets the neurological source of wanting. This distinction matters: if your issue is desire (you don’t feel the drive) rather than performance (the plumbing doesn’t work), PT-141 addresses the root.

PT-141 is prescribed for both men and women. Your provider explains how and when it is used. Common side effects include temporary flushing, mild nausea, and occasional headache — generally mild and short-lived.

For men, PT-141 (bremelanotide), a desire-support peptide, may be used alongside blood-flow medication such as Cialis or Viagra. For women, your provider may discuss it for persistently low interest in sexual activity. Individual results vary.

At Balanced, PT-141 is part of a broader sexual health plan, not a standalone prescription. We evaluate hormones, cortisol, sleep quality, and relationship context to build a comprehensive approach. PT-141 handles the desire signal; hormone optimization handles the underlying biology; and lifestyle modification handles the environmental factors.

Sexual Health →  ·  Peptide Therapy →